General MedicationsINJECTIONGeneric
ACUTECT
TECHNETIUM TC-99M APCITIDE
Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview ACUTECT is listed in Drugs@FDA under application 020887 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient TECHNETIUM TC-99M APCITIDE Form and strength INJECTABLE;INJECTION - N/A Sponsor CIS BIO INTL SA Submission history Latest submission status date: 2002-01-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview ACUTECT is listed in Drugs@FDA under application 020887 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient TECHNETIUM TC-99M APCITIDE Form and strength INJECTABLE;INJECTION - N/A Sponsor CIS BIO INTL SA Submission history Latest submission status date: 2002-01-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.